Polysaccharides improve cognitive impairment in mice: A meta-analysis

Xin-Chen Wang1, Chen-Liang Chu2, Yan-Lu Liu2

  • 1Department of Pharmaceutical Engineering, College of Food and Pharmaceutical Engineering, Zhaoqing University, Zhaoqing, China; Guangdong Provincial Key Laboratory of Environmental Health and Resource Utilization, Zhaoqing University, Zhaoqing, China; School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, 3 Sassoon Road, Pokfulam, Hong Kong SAR, China.

Abstract

Insights

Polysaccharide (PS) extracts significantly improved cognitive and behavioral abilities in mouse models of mild cognitive impairment (MCI). These findings highlight PS as a potential therapeutic agent for MCI by enhancing neuronal function and reducing inflammation and oxidative stress.

Area of Science:

  • Neuroscience and Pharmacology
  • Biochemistry and Molecular Biology

Background:

  • Mild cognitive impairment (MCI) is a transitional stage between normal aging and dementia, characterized by deficits in cognition, behavior, and language.
  • Polysaccharides (PS) are bioactive compounds with known immunomodulatory, anti-inflammatory, and antioxidant properties, and they can promote neuronal growth.

Purpose of the Study:

  • To systematically review and meta-analyze existing research on the efficacy of polysaccharide (PS) extracts in improving cognitive and behavioral deficits in animal models of mild cognitive impairment (MCI).
  • To evaluate the impact of PS extracts on behavioral performance and key biochemical indicators associated with MCI.

Main Methods:

  • A comprehensive systematic search of electronic databases (PubMed, Web of Science, Cochrane Library, Embase, MEDLINE) was conducted up to April 2025.
  • Included studies involved mouse models of MCI induced by various methods, comparing outcomes between PS extract treatment groups and control groups.
  • Data were analyzed using a random effects model, adhering to Cochrane systematic review and PRISMA guidelines to assess intergroup heterogeneity.

Main Results:

  • The meta-analysis included 84 studies across 9 mouse strains and over 40 types of PS, examining 6 mechanisms of action.
  • PS treatment significantly improved performance in behavioral tests, including the Morris water maze (SMD=-2.19), Y-maze (SMD=0.12), and new object recognition test (SMD=0.2).
  • Significant differences were observed in biochemical markers, with PS intervention positively affecting acetylcholinesterase activity, oxidative stress markers (superoxide dismutase and malondialdehyde), and anti-inflammatory effects compared to untreated MCI models.

Conclusions:

  • Polysaccharide (PS) extracts demonstrate a significant capacity to enhance learning and cognitive functions in animal models of mild cognitive impairment (MCI).
  • The therapeutic effects are attributed to multiple mechanisms, including the promotion of neuronal regeneration, and the exhibition of anti-inflammatory, antioxidant, and anti-protein aggregation properties.